Posters

The Starflo glaucoma implant: results and experiences after follow-up of 1 year in St. Johannes Hospital in Dortmund

Poster Details

First Author: S.Fili GERMANY

Co Author(s):    E. Papadopoulou   P. Woelfelschneider   M. Kohlhaas              

Abstract Details

Purpose:

To investigate the safety and effectiveness of the Starflo implant. The results of 1 year follow-up are presented in patients with open-angle glaucoma, PEX-Gaucom and congenital glaucoma.

Setting:

Clinic of Ophthalmology, St.-Johannes-Hospital in Dortmund, Germany

Methods:

A prospective study with a total of over 20 patients, in which the suprachoroidal implantation of the StarfloTM was indicated for long-term intraocular pressure reduction is still in process and evaluation.

Results:

No intraoperative complications have been reported after the implantation of Starflo. Postoperative complications include hyphema and fibrin formation in the anterior chamber, which were completely resorbed after the first postoperative month. A postoperative bulbar hypertension was the most common complication after the first 3 months. The reduction of IOP was satisfying after 6 months. The reduction of the local antiglaucoma drops was significant for a maximum of two substance 6 months postoperatively. A small number of patients needed a further surgery to regulate the intraocular pressure. Another advantage of Starflo-implantation is the relatively short learning curve for experienced ophthalmic surgeons.

Conclusions:

The Starflo implant appears to be a safe and effective alternative treatment method for patients with refractory open-angle glaucoma to conventional glaucoma surgery.

Financial Disclosure:

NONE